ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/4/2022ACC: 0001209191-22-052359
Officer· Interim CFO
Since Jun 2021
-353.00
Net shares
Net seller
$78.72
Total sold
0
Open market trades
0B · 0S
1
Total transactions
353.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−353.00
Price / share
$0.22
Trade value
$78.72
% of position
0.2%
9/30/2022
173.71K→173.36K
Total
Net shares
−353.00
Net value
-$78.72
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2022 | F · Tax Withholding | −353.00 | $0.22 | $78.72 | 0.2% | 173.71K | 173.36K |
| Total | −353.00 | -$78.72 | ||||||
Derivative Transactions0
No derivative transactions reported